BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 15670976)

  • 1. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G modulates immune responses by diverse receptor interactions.
    Hofmeister V; Weiss EH
    Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.
    Chen LJ; Han ZQ; Zhou H; Zou L; Zou P
    Placenta; 2010 Jun; 31(6):519-27. PubMed ID: 20430441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
    Yan WH; Fan LA
    Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy.
    Yan WH; Lin A; Chen BG; Zhou MY; Dai MZ; Chen XJ; Gan LH; Zhu M; Shi WW; Li BL
    Am J Reprod Immunol; 2007 Apr; 57(4):233-42. PubMed ID: 17362384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine induces up-regulation of immunoglobulin-like transcripts 3 and 4 expression on and activity of NKL cells.
    Si YQ; Bian XK; Lu N; Jia YF; Hou ZH; Zhang Y
    Transplant Proc; 2012 Jun; 44(5):1407-11. PubMed ID: 22664025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?
    Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED
    Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
    Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
    Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
    Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.
    Biedroń M; Rybka J; Wróbel T; Prajs I; Poręba R; Kuliczkowski K
    Med Oncol; 2015 Aug; 32(8):219. PubMed ID: 26187179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4.
    Chang CC; Ciubotariu R; Manavalan JS; Yuan J; Colovai AI; Piazza F; Lederman S; Colonna M; Cortesini R; Dalla-Favera R; Suciu-Foca N
    Nat Immunol; 2002 Mar; 3(3):237-43. PubMed ID: 11875462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction.
    Gómez-Lozano N; de Pablo R; Puente S; Vilches C
    Eur J Immunol; 2003 Mar; 33(3):639-44. PubMed ID: 12616484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.